CollPlant Biotechnologies CLGN
NASDAQ CLGN
$4.12 +0.09 (+2.23%)
At close: Nov 9, 2026 · 4:00 PM EST

CollPlant Biotechnologies (CLGN) Return on Equity [ROE] (2018 - 2026)

Updated

CollPlant Biotechnologies (CLGN) recorded Return on Equity [ROE] of -68.89% in the quarter ended Dec 31, 2025, down 14.09 percentage points from -54.80% a year earlier but up 64.56 percentage points from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, CollPlant Biotechnologies reported Return on Equity [ROE] of -117.56%, down 38.10 percentage points from the prior year.

  • Annual Return on Equity [ROE] has a five-year change of -252.39 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Equity [ROE] came in at -79.46% in the year ended Dec 31, 2024 (-56.30 pp), -23.16% in the year ended Dec 31, 2023 (+20.58 pp), -43.73% in the year ended Dec 31, 2022 (-44.88 pp) and 1.15% in the year ended Dec 31, 2021 (-133.68 pp).
  • Quarterly Return on Equity [ROE] has ranged from -133.45% in the quarter ended Sep 30, 2025 to 77.68% in the quarter ended Mar 31, 2021 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] rose in three of the last six quarters, with an average year-over-year change of -17.76 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 57.27 percentage points in the quarter ended Mar 31, 2024, against a drop of 323.40 percentage points in the quarter ended Sep 30, 2021 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 19.33%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.63%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 21.60%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 72.13%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -31.17%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.66%
10 CollPlant Biotechnologies 4.98 Mn -17.38 Mn -456,000.00 -316.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -316.82%
Mar 31, 2026 -236.16%
Dec 31, 2025 -149.27%
Sep 30, 2025 -112.86%
Jun 30, 2025 -107.16%
Mar 31, 2025 -112.67%
Dec 31, 2024 -56.56%
Sep 30, 2024 -51.46%
Jun 30, 2024 -43.15%
Mar 31, 2024 1.27%
Dec 31, 2023 -1.56%
Sep 30, 2023 -0.24%
Jun 30, 2023 0.16%
Mar 31, 2023 -31.56%
Dec 31, 2022 -28.08%
Sep 30, 2022 -23.00%
Jun 30, 2022 -17.44%
Mar 31, 2022 -13.61%
Dec 31, 2021 0.68%
Sep 30, 2021 26.01%
API Access

CollPlant Biotechnologies Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLGN&period=max&api_key=YOUR_API_KEY